Large drugmakers with the fastest revenue growth

Ranked

97

of 412 large drugmakers we cover

Median

+11.7%

Highest

+280.5%

CRMD

Range

−70.1% to +280.5%

#	Company	Revenue growth	Net margin	Price to sales	Market cap
1	CRMDCorMedix	+280.5%	40.5%	1.3×	$611.9M
2	SNDXSyndax Pharmaceuticals	+222.7%	−87.5%	4.7×	$1.2B
3	BCYCBicycle Therapeutics	+217.4%	n/m	4.1×	$248.5M
4	BBIOBridgeBio Pharma	+202.4%	−97.0%	18.8×	$13.4B
5	MDGLMadrigal Pharmaceuticals	+149.0%	−25.3%	7.8×	$10B
6	AGIOAgios Pharmaceuticals	+140.6%	n/m	22.5×	$2.2B
7	ASMBAssembly Biosciences	+125.1%	−0.1%	5.4×	$404M
8	TNGXTango Therapeutics	+121.5%	n/m	73.1×	$3.9B
9	ZVRAZevra Therapeutics	+119.4%	42.8%	4.3×	$582.6M
10	PHATPhathom Pharmaceuticals	+110.2%	−41.3%	1.9×	$464.4M
11	ABCLAbCellera Biologics	+101.3%	n/m	54.8×	$3.6B
12	URGNUroGen Pharma	+100.3%	−51.7%	8.9×	$1.7B
13	TVTXTravere Therapeutics	+77.1%	−7.4%	8.0×	$4.7B
14	ARQTArcutis Biotherapeutics	+76.1%	6.1%	8.5×	$3.9B
15	TGTXTG Therapeutics	+76.1%	55.2%	10.4×	$8.3B
16	KNSAKiniksa Pharmaceuticals International	+58.9%	9.6%	7.1×	$6B
17	AXSMAxsome Therapeutics	+56.9%	−24.7%	9.8×	$7.6B
18	LGNDLigand Pharmaceuticals	+54.9%	67.9%	20.8×	$6.1B
19	RYTMRhythm Pharmaceuticals	+53.5%	−85.6%	25.6×	$6.1B
20	LLYEli Lilly and	+49.6%	33.5%	15.0×	$1.2T
21	MIRMMirum Pharmaceuticals	+44.0%	n/m	8.4×	$5.2B
22	XERSXeris Biopharma	+36.3%	−5.1%	5.5×	$1.9B
23	PTGXProtagonist Therapeutics	+34.8%	29.4%	31.8×	$9B
24	GOSSGossamer Bio	+32.4%	n/m	1.1×	$58.7M
25	ANIPANI Pharmaceuticals	+30.9%	11.1%	1.7×	$1.7B
26	MNKDMannkind	+30.5%	−11.1%	2.6×	$1B
27	IRWDIronwood Pharmaceuticals	+26.2%	33.4%	1.5×	$571.7M
28	SUPNSupernus Pharmaceuticals	+24.9%	−13.2%	2.8×	$2.4B
29	GERNGeron	+24.4%	−33.1%	3.5×	$719.6M
30	HRMYHarmony Biosciences	+24.3%	18.9%	2.2×	$2.1B
31	AQSTAquestive Therapeutics	+22.6%	n/m	9.3×	$502M
32	HROWHarrow	+21.1%	−13.5%	3.9×	$1.1B
33	DERMJourney Medical	+20.9%	−9.0%	2.1×	$141.7M
34	AUPHAurinia Pharmaceuticals	+19.8%	n/m	7.2×	$2.2B
35	INVAInnoviva	+18.8%	81.2%	3.4×	$1.5B
36	RAREUltragenyx Pharmaceutical	+17.4%	−81.7%	2.2×	$1.5B
37	PAHCPhibro Animal Health	+17.1%	6.6%	1.0×	$1.6B
38	ARWRArrowhead Pharmaceuticals	+16.8%	−47.8%	12.2×	$8.2B
39	ARDXArdelyx	+16.8%	−12.4%	1.7×	$767.5M
40	CORTCorcept Therapeutics	+16.0%	6.6%	11.2×	$9.3B
41	COLLCollegium Pharmaceutical	+14.3%	5.9%	0.9×	$747.5M
42	EOLSEvolus	+13.9%	−10.8%	1.5×	$463M
43	GYREGyre Therapeutics	+13.5%	−15.5%	5.5×	$652.3M
44	INDVIndivior Pharmaceuticals	+13.5%	26.7%	3.1×	$4.1B
45	JAZZJazz Pharmaceuticals	+12.6%	20.4%	3.0×	$13.9B
46	CYRXCryoport	+12.1%	−20.1%	4.9×	$910.7M
47	ELANElanco Animal Health	+12.0%	−4.0%	2.2×	$11.3B
48	ACADAcadia Pharmaceuticals	+11.8%	33.4%	3.0×	$3.4B
49	MGNXMacrogenics	+11.7%	−8.7%	0.9×	$143.3M
50	BMRNBiomarin Pharmaceutical	+11.2%	2.1%	3.2×	$10.8B
51	ALKSAlkermes plc.	+10.8%	4.0%	4.4×	$7.3B
52	ABBVAbbVie	+10.4%	9.8%	7.8×	$504.8B
53	BHCBausch Health Companies	+10.1%	−10.1%	0.2×	$2.4B
54	AMRXAmneal Pharmaceuticals	+9.3%	5.0%	2.1×	$6.5B
55	AMGNAmgen	+9.1%	23.0%	6.2×	$237.5B
56	SDGRSchrodinger	+8.9%	−21.0%	6.9×	$1.8B
57	JNJJohnson & Johnson	+7.8%	n/m	6.4×	$635.8B
58	AKBAAkebia Therapeutics	+7.5%	−13.5%	0.7×	$157.1M
59	KPTIKaryopharm Therapeutics	+6.8%	n/m	0.1×	$11.7M
60	NATRNatures Sunshine Products	+6.8%	3.7%	0.4×	$213.8M
61	ORGOOrganogenesis	+6.5%	−18.4%	0.3×	$127.8M
62	VNDAVanda Pharmaceuticals	+6.0%	n/m	1.1×	$242.5M
63	PCRXPacira BioSciences	+5.7%	2.0%	1.9×	$1.5B
64	GILDGilead Sciences	+5.5%	−10.6%	6.4×	$193.5B
65	ZLABZai Lab	+5.1%	−41.9%	6.0×	$2.7B
66	MRKMerck	+4.6%	4.8%	5.4×	$358.4B
67	SPRYARS Pharmaceuticals	+4.1%	n/m	3.4×	$400.8M
68	RIGLRigel Pharmaceuticals	+3.3%	n/m	3.2×	$899.1M
69	BMYBristol-Myers Squibb	+3.1%	18.9%	2.6×	$125.6B
70	ADCTADC Therapeutics SA	+3.0%	n/m	2.3×	$183.8M
71	AMPHAmphastar Pharmaceuticals	+1.0%	10.8%	1.5×	$1.1B
72	HRTXHeron Therapeutics	+1.0%	−22.5%	0.4×	$57.5M
73	ENTAEnanta Pharmaceuticals	+0.7%	−96.9%	5.2×	$339M
74	BIIBBiogen	+0.3%	8.3%	3.7×	$37B
75	PFEPfizer	−0.2%	6.8%	2.7×	$171.2B
76	PBHPrestige Consumer Healthcare	−1.4%	15.6%	2.0×	$2.3B
77	OGNOrganon	−2.5%	3.4%	0.6×	$3.6B
78	PBYIPuma Biotechnology	−2.9%	11.6%	2.5×	$568.9M
79	PRGOPERRIGO	−4.2%	−41.9%	0.5×	$2.2B
80	MRVIMaravai Lifesciences	−5.0%	−37.1%	9.1×	$1.9B
81	IONSIonis Pharmaceuticals	−7.4%	−64.7%	8.2×	$7.1B
82	OCULOcular Therapeutix	−8.1%	n/m	27.4×	$1.4B
83	EBSEmergent BioSolutions	−9.6%	−23.0%	0.4×	$319.4M
84	OPKOpko Health	−11.5%	−12.4%	2.1×	$1.2B
85	AYTUAytu Biopharma	−13.3%	−24.8%	0.4×	$20.6M
86	ARVNArvinas	−15.0%	2.9%	1.5×	$477.3M
87	AMRNAmarin Corp Plc	−15.1%	−14.6%	1.3×	$249M
88	LFVNLifevantage	−20.1%	2.8%	0.4×	$73.4M
89	SRPTSarepta Therapeutics	−20.4%	−6.9%	0.9×	$1.9B
90	CYTKCytokinetics	−21.1%	n/m	126×	$8.5B
91	RMTIRockwell Medical	−21.1%	−7.3%	0.4×	$28M
92	LABStandard Biotools	−23.6%	n/m	2.8×	$237.7M
93	NKTRNektar Therapeutics	−27.2%	n/m	23.3×	$1.3B
94	XNCRXencor	−28.6%	n/m	17.8×	$1.9B
95	PTCTPTC Therapeutics	−42.8%	−3.8%	5.0×	$5.1B
96	RCUSArcus Biosciences	−55.3%	n/m	20.2×	$2.4B
97	SIGASiga Technologies	−70.1%	−5.2%	4.2×	$224.2M

Not ranked: 106 with not a meaningful number, 62 with a quarter missing, 52 with under $50M of revenue, 15 with growth from a base too small to compare. 80 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.